Loading Events

« All Events

Peripheral and Central Nervous System Drugs Advisory Committee

November 6

The committee will discuss biologics license application (BLA) 761178, for aducanumab solution for intravenous infusion, submitted by Biogen Inc., for the treatment of Alzheimer’s disease.

Details

Date:
November 6
Event Category: